148 related articles for article (PubMed ID: 31344153)
1. [Antimicrobial therapy in cancer patients and hematopoietic stem cell transplantation receptors].
Santolaya ME; Álvarez AM; Bidart T; Morales J; González C
Rev Chilena Infectol; 2019 Apr; 36(2):167-178. PubMed ID: 31344153
[TBL] [Abstract][Full Text] [Related]
2. Inpatient Antibiotic Stewardship Interventions in the Adult Oncology and Hematopoietic Stem Cell Transplant Population: A Review of the Literature.
Pillinger KE; Bouchard J; Withers ST; Mediwala K; McGee EU; Gibson GM; Bland CM; Bookstaver PB
Ann Pharmacother; 2020 Jun; 54(6):594-610. PubMed ID: 31771337
[No Abstract] [Full Text] [Related]
3. Antimicrobial de-escalation in adult hematopoietic cell transplantation recipients with febrile neutropenia of unknown origin.
Petteys MM; Kachur E; Pillinger KE; He J; Copelan EA; Shahid Z
J Oncol Pharm Pract; 2020 Apr; 26(3):632-640. PubMed ID: 31423947
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial stewardship in patients with cancer.
Tverdek FP; Rolston KV; Chemaly RF
Pharmacotherapy; 2012 Aug; 32(8):722-34. PubMed ID: 23307520
[TBL] [Abstract][Full Text] [Related]
5. Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update.
Lehrnbecher T; Robinson P; Fisher B; Alexander S; Ammann RA; Beauchemin M; Carlesse F; Groll AH; Haeusler GM; Santolaya M; Steinbach WJ; Castagnola E; Davis BL; Dupuis LL; Gaur AH; Tissing WJE; Zaoutis T; Phillips R; Sung L
J Clin Oncol; 2017 Jun; 35(18):2082-2094. PubMed ID: 28459614
[TBL] [Abstract][Full Text] [Related]
6. Risk Adapted Management of Febrile Neutrepenia and Early Cessation of Empirical Antibiotherapy in Hematopoietic Stem Cell Transplantation Setting.
Kaya AH; Tekgündüz E; Duygu F; Koca D; Bekdemir F; Batgi H; Ulu Uncu B; Yiğenoğlu TN; Dal MS; Çakar Kızıl M; Altuntaş F
Balkan Med J; 2017 Apr; 34(2):132-139. PubMed ID: 28418340
[TBL] [Abstract][Full Text] [Related]
7. Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: comparison between patients with lymphoma or multiple myeloma and patients with solid tumors.
Reich G; Mapara MY; Reichardt P; Dörken B; Maschmeyer G
Bone Marrow Transplant; 2001 Mar; 27(5):525-9. PubMed ID: 11313687
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of sepsis biomarkers in hematopoietic stem cell transplant recipients in a condition of high prevalence of gram-negative pathogens.
Stoma I; Karpov I; Uss A; Rummo O; Milanovich N; Iskrov I
Hematol Oncol Stem Cell Ther; 2017 Mar; 10(1):15-21. PubMed ID: 27793578
[TBL] [Abstract][Full Text] [Related]
9. The utility of routine chest radiography in the initial evaluation of adult patients with febrile neutropenia patients undergoing HSCT.
Yolin-Raley DS; Dagogo-Jack I; Niell HB; Soiffer RJ; Antin JH; Alyea EP; Glotzbecker BE
J Natl Compr Canc Netw; 2015 Feb; 13(2):184-9. PubMed ID: 25691611
[TBL] [Abstract][Full Text] [Related]
10. A change for the antibacterial treatment policy to decrease carbapenem consumption at a haematopoietic stem cell transplantation centre.
Metan G; Kaynar L; Yozgat N; Elmali F; Kürkçüoglu CA; Alp E; Çetin M
Infez Med; 2017 Mar; 25(1):33-37. PubMed ID: 28353453
[TBL] [Abstract][Full Text] [Related]
11. Adverse effects of antibiotics in children with cancer: are short-course antibiotics for febrile neutropenia part of the solution?
Butters C; Thursky K; Hanna DT; Cole T; Davidson A; Buttery J; Haeusler G
Expert Rev Anti Infect Ther; 2023 Mar; 21(3):267-279. PubMed ID: 36694289
[TBL] [Abstract][Full Text] [Related]
12. Piperacillin-tazobactam vs. imipenem-cilastatin as empirical therapy in hematopoietic stem cell transplantation recipients with febrile neutropenia.
Jing Y; Li J; Yuan L; Zhao X; Wang Q; Yu L; Zhou D; Huang W
Clin Transplant; 2016 Mar; 30(3):263-9. PubMed ID: 26701371
[TBL] [Abstract][Full Text] [Related]
13. Adherence to practice guidelines for the management of febrile neutropenia in patients undergoing hematopoietic stem cell transplantation: An observational study in a referral center in Iran.
Ekhtiari Kolour SR; Shahrami B; Kargar M; Taghvaye Masoumi H; Amini S; Vaezi M; Hadjibabaie M; Mohammadi M; Sadeghi K
J Oncol Pharm Pract; 2023 Jul; 29(5):1112-1118. PubMed ID: 35392730
[TBL] [Abstract][Full Text] [Related]
14. New agents for the prevention of opportunistic infections in haematopoietic stem cell transplant recipients.
Zuccotti G; Strasfeld L; Weinstock DM
Expert Opin Pharmacother; 2005 Aug; 6(10):1669-79. PubMed ID: 16086653
[TBL] [Abstract][Full Text] [Related]
15. Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for malignancies.
Celebi H; Akan H; Akçağlayan E; Ustün C; Arat M
Bone Marrow Transplant; 2000 Jul; 26(2):211-4. PubMed ID: 10918433
[TBL] [Abstract][Full Text] [Related]
16. Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation.
Salazar R; Solá C; Maroto P; Tabernero JM; Brunet J; Verger G; Valentí V; Cancelas JA; Ojeda B; Mendoza L; Rodríguez M; Montesinos J; López-López JJ
Bone Marrow Transplant; 1999 Jan; 23(1):27-33. PubMed ID: 10037047
[TBL] [Abstract][Full Text] [Related]
17. Empiric antimicrobial therapy of febrile neutropenic patients undergoing haematopoietic stem cell transplantation.
Antabli BA; Bross P; Siegel RS; Small CD; Tabbara IA
Int J Antimicrob Agents; 1999 Oct; 13(2):127-30. PubMed ID: 10595571
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes.
Jeddi R; Achour M; Amor RB; Aissaoui L; Bouterâa W; Kacem K; Lakhal RB; Abid HB; BelHadjAli Z; Turki A; Meddeb B
Hematology; 2010 Feb; 15(1):28-32. PubMed ID: 20132659
[TBL] [Abstract][Full Text] [Related]
19. Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial.
Aguilar-Guisado M; Espigado I; Martín-Peña A; Gudiol C; Royo-Cebrecos C; Falantes J; Vázquez-López L; Montero MI; Rosso-Fernández C; de la Luz Martino M; Parody R; González-Campos J; Garzón-López S; Calderón-Cabrera C; Barba P; Rodríguez N; Rovira M; Montero-Mateos E; Carratalá J; Pérez-Simón JA; Cisneros JM
Lancet Haematol; 2017 Dec; 4(12):e573-e583. PubMed ID: 29153975
[TBL] [Abstract][Full Text] [Related]
20. Guideline for primary antifungal prophylaxis for pediatric patients with cancer or hematopoietic stem cell transplant recipients.
Science M; Robinson PD; MacDonald T; Rassekh SR; Dupuis LL; Sung L
Pediatr Blood Cancer; 2014 Mar; 61(3):393-400. PubMed ID: 24424789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]